ACEi to ARNi: "The Switch" An Evidence Based Review

<p>Heart failure affects approximately 6.5 million adults in the United States, and the cost to healthcare system is tremendous [1]. Effective treatment for this very important disease is constantly evolving. The most significant change in the recent past has been the development of ARNI (Sacu...

Full description

Saved in:
Bibliographic Details
Main Authors: Yusuf Hassan (Author), Zahra Hassan (Author), Ayesha Hassan (Author), Asad A Saleem (Author), Waqas Ahmed (Author)
Format: Book
Published: Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications, 2020-10-30.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_2455-2976_000154
042 |a dc 
100 1 0 |a Yusuf Hassan  |e author 
700 1 0 |a  Zahra Hassan  |e author 
700 1 0 |a  Ayesha Hassan  |e author 
700 1 0 |a  Asad A Saleem  |e author 
700 1 0 |a Waqas Ahmed  |e author 
245 0 0 |a ACEi to ARNi: "The Switch" An Evidence Based Review 
260 |b Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications,   |c 2020-10-30. 
520 |a <p>Heart failure affects approximately 6.5 million adults in the United States, and the cost to healthcare system is tremendous [1]. Effective treatment for this very important disease is constantly evolving. The most significant change in the recent past has been the development of ARNI (Sacubitril/ Valsartan) for treatment of heart failure [2].</p><p><br></p> 
540 |a Copyright © Yusuf Hassan et al. 
546 |a en 
655 7 |a Review Article  |2 local 
856 4 1 |u https://doi.org/10.17352/2455-2976.000154  |z Connect to this object online.